Drug Type Small molecule drug |
Synonyms 1-Butyl-3-(p-methylphenylsulfonyl)urea, 1-Butyl-3-(p-tolylsulfonyl)urea, 1-Butyl-3-tosylurea + [14] |
Target |
Mechanism Kir6.2 stimulants(potassium inwardly rectifying channel subfamily J member 11 stimulants), SUR1 inhibitors(Sulfonylurea receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (31 May 1957), |
Regulation- |
Molecular FormulaC12H18N2O3S |
InChIKeyJLRGJRBPOGGCBT-UHFFFAOYSA-N |
CAS Registry64-77-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00380 | Tolbutamide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | US | 31 May 1957 |